TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review

Overview of attention for article published in Frontiers in oncology, December 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 18,796 followers.

TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review https://t.co/jFVkdOZBto https://t.co/QNhsD0WTlf

08 Jan 2024

Reply Repost Favourite

RT @FrontOncology: New research: TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review: Triple-negative brea…

13 Dec 2023

Reply Repost Favourite

New research: TRPML1 as a potential therapeutic target for triple-negative breast cancer: a review: Triple-negative breast cancer (TNBC) is the most refractory subtype of breast cancer, and effective treatments are urgently needed owing to its… https://t.c

13 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.